Lang H, Würzburg U, Neumeier D, Knedel M, Prellwitz W, Kattermann R, Schlebusch H, Schürmann J
Klin Wochenschr. 1978 Jul 1;56(13):641-6. doi: 10.1007/BF01477017.
By differentiation of creatine kinase isoenzyme activities in sera using immunological methods the published data about occurrence of creatine kinase BB activities in patients with different diseases or after surgical treatment, respectively, cannot be verified in general. With a frequency in the order of magnitude of 1 : 1000 in the serum of old patients (age 57 to 85 years with one exception), however, creatine kinase BB activities can be measured. The range of activities is 15 to 234 U/1, or 19 to 94% of total creatine kinase activities, respectively. At the present time there is no possibility to correlate this phenomenon to any specific disease. These cases are detected by abnormally high results of CK-MB activity measurements with the immunoinhibition test (range 60 to 202% of total creatine kinase activities) which lead to a repeated analysis using immunoprecipitation. The results of all CK-BB patients investigated till now are presented and discussed.
采用免疫学方法对血清中肌酸激酶同工酶活性进行鉴别时,已发表的关于不同疾病患者或外科治疗后血清中肌酸激酶BB活性出现情况的数据,总体上无法得到验证。然而,在老年患者(年龄57至85岁,有1例除外)的血清中,肌酸激酶BB活性的出现频率约为千分之一,可以检测到。活性范围分别为15至234 U/1,或占总肌酸激酶活性的19%至94%。目前,无法将这种现象与任何特定疾病相关联。这些病例是通过免疫抑制试验中肌酸激酶MB活性测量结果异常高(占总肌酸激酶活性的60%至202%)而检测到的,这导致使用免疫沉淀法进行重复分析。本文展示并讨论了迄今为止所有已调查的肌酸激酶BB患者的结果。